Table 2

Pharmacokinetic parameters of YM796 in rats, dogs and humans

i.v. administrationDoseAUCiv CLtot t 1/2
 Species n (mg/kg)(ng · hr/ml)(ml/min/kg)(hr)
  Rat30.344.7 1120.36
  Dog30.154.5  (5.6)31.2  (3.3)0.89  (0.19)
Oral administrationDoseAUCoral CLoral Cmax F
 Species n (mg/kg)(ng · hr/ml)(ml/min/kg)(ng/ml)(%)
  Rat31.0 5.033309.3 3.4
  Dog31.087.7  (17.0)205  (39)39.3  (7.1)16.1  (2.5)
  Human1-a 65.01-b 117  (16)11.1  (1.3)19.8  (2.1)
Other parameters
 Species n fp 1-c RB 1-c
  Rat30.694  (0.013)1.10  (0.08)
  Dog30.707  (0.006)1.07  (0.05)
  Human1-a 30.700  (0.013)1.11  (0.07)
  • Numbers in parentheses represent the S.E. of the mean values.

  • 1-a The human data were taken from Iwatsubo et al., 1997b.

  • 1-b The dose was given as mg/body for humans different from rats and dogs.

  • 1-c Both fp and RB were almost constant irrespective of YM796 concentrations ranging from 0.5 to 2500 μM in all species examined.